Highbridge Capital Management LLC Verastem, Inc. Transaction History

Highbridge Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $3.29 Million - $8.18 Million	-1,948,122 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $2.42 Million - $6.5 Million	1,923,922 Added 7950.09%	1,948,122 $5.14 Million
Q4 2019 Feb 14, 2020	BUY	$0.86 - $1.44 $20,812 - $34,848	24,200 New	24,200 $32,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $554,400 - $1.67 Million	-192,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.99 - $4.85 $276,575 - $448,624	92,500 Added 92.5%	192,500 $591,000
Q2 2017 Aug 14, 2017	BUY	N/A	100,000	100,000 $218,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.17B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.